Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia
Thomas Orfeo , Jonathan H. Foley , Saulius Butenas , Matthew Gissel
Thrombosis Research 130 ( 6) 948 -955
32
2012
Hi‐Fi SELEX: A high‐fidelity digital‐PCR based therapeutic aptamer discovery platform
Eric Ouellet , Jonathan H. Foley , Edward M. Conway , Charles Haynes
Biotechnology and Bioengineering 112 ( 8) 1506 -1522
50
2015
Modulation of Complement Activation and Amplification on Nanoparticle Surfaces by Glycopolymer Conformation and Chemistry
Kai Yu , Benjamin F. L. Lai , Jonathan H. Foley , Michael J. Krisinger
ACS Nano 8 ( 8) 7687 -7703
56
2014
Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin
Jonathan H. Foley , Bethany L. Walton , Maria M. Aleman , Alice M. O'Byrne
EBioMedicine 5 175 -182
108
2016
An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A
Catherine J. Rea , Jonathan H. Foley , David H. Bevan , Benny Sørensen
Annals of Hematology 93 ( 4) 683 -692
8
2014
Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A
C. J. REA , J. H. FOLEY , J. INGERSLEV , B. SØRENSEN
Journal of Thrombosis and Haemostasis 9 ( 3) 510 -516
22
2011
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A
J. H. FOLEY , M. E. NESHEIM , G. E. RIVARD , K. E. BRUMMEL-ZIEDINS
Haemophilia 18 ( 3)
20
2012
Plasmin Cleaves Complement iC3b, Preventing CR3/4 Mediated Phagocytosis By Macrophages
Erica A. Peterson , Jonathan H Foley , Michael J Krisinger , Edward Conway
Blood 122 ( 21) 1105 -1105
2013
Procoagulant Activity In Stored Units Of Red Blood Cells
Saulius Butenas , Maya Aleshnick , Jonathan H Foley , Friederike K. Keating
Blood 122 ( 21) 1157 -1157
2013
Nebulized recombinant tissue plasminogen activator (rt-PA) for acute COVID-19-induced respiratory failure: an exploratory proof-of-concept trial
Pratima Chowdary , Banwari Agarwal , Maria Rita Peralta , Sanjay Bhagani
Journal of Clinical Medicine 12 ( 18) 5848 -5848
1
2023
Nebulized recombinant tissue plasminogen activator (rt-PA) for acute COVID-19-induced severe respiratory failure: an exploratory proof of concept trial
Pratima Chowdary , Banwari Agarwal , Maria Rita Peralta , Sanjay Bhagani
Preprints
2023
Utilising Apheresis to Remove Neutralising AAV Antibodies in Patients Previously Excluded from Gene Therapy
Jonathan H Foley , Erald Shehu , Allison Dane , Rose Sheridan
MOLECULAR THERAPY 28 ( 4) 516 -516
2020
Evaluation and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU)
Jonathan H Foley , Paul Y Kim , Dirk Hendriks , John Morser
Differences in wild-type–and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies
Jonathan H Foley , Erald Shehu , Anne Riddell , Elaine Gray
Blood Advances 7 ( 3) 458 -467
7
2023
Protein engineering in FLT210, a Potent Next Generation AAV-hFVIII Vector Candidate
Tihomir Dodev , Petya Kalcheva , Azadeh Kia , Samantha Correia
Protein Engineering Summit PEGS
2020
Thrombosis Compendium
Jonathan H Foley , Edward M Conway
2016
ted
Eric Ouellet , Jonathan H Foley , Edward M Conway , Charles Haynes
Factor XIII in the Treatment of Hemophilia A
Catherine J Rea , Jonathan H Foley , Benny Sørensen ,
New England Journal of Medicine 366 ( 3) 281 -283
12
2012
Treatment of coagulopathy with hyperfibrinolysis
Karl-Uwe Petersen , Michael Ernest Nesheim , Daniel Nesheim , Jonathan Herbert Foley
1
2012